Pretreatment systemic inflammation response index (SIRI) is an independent predictor of survival in unresectable stage III non-small cell lung cancer treated with chemoradiotherapy: a two-center retrospective study
Hu, Min, Xu, Qinghua, Yang, Shuangyan, Han, Shuiyun, Zhu, Yaoyao, Lin, Qingren, Sun, Xiaojiang, Liu, Hui, Xu, YapingVolume:
8
Journal:
Annals of Translational Medicine
DOI:
10.21037/atm-20-6484
Date:
October, 2020
File:
PDF, 539 KB
2020